First in Human Phase I Trial of Dual Vector (HSV1‐TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High‐Grade Glioma: Initial Results. (September 2019) - Orringer, Daniel A; Sagher, Oren; Heth, Jason; Hervey‐Jumper, Shawn L; Mammoser, Aaron; Junck, Larry; Leung, Denise; Umemura, Yoshie; Lawrence, Theodore; Kim, Michelle; Wahl, Dan; McKeever, Paul; et al.